FindTrial
Sign In

Homeopathic formulation for Flu and Flu like symptoms.

An open Label, non-randomised, clinical study to evaluate the efficacy of homeopathic formulation of Anacosinum pellets in patient with Flu and Flu like symptoms.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021351
Enrollment
200
Registered
2019-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J101- Influenza due to other identifiedinfluenza virus with other respiratory manifestations

Interventions

Intervention1: Anacosinum Pellets: All eligible subjects who meet the Inclusion and Exclusion will be enrolled into the study will have to visit the study site on screening, Day 0 (Baseline visit) and

Sponsors

Bhargava Phytolab Limited
Lead Sponsor
Milagro Clinical Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The Inclusion criteria are as follows (â??Yesâ?? to all the following will allow the subjects to be included into study) 1 Age: Adult-Above 18 years to below 60 years, both male and female 2 Willing to sign written inform consent 3 Patients recently diagnosed with Flu, the following signs and symptoms Diagnosis of Mild to Moderate Headache, Body ache and other symptoms of cough cold. Sore throat. Sneezing/ Nasal irritation. Headache. Cough. Runny nose. Malaise. With or without low grade fever (

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows (â??Yesâ?? to any one of the following will allow PI to exclude the subject from enrolling into the study 1 Upper Respiratory Tract Infections (URI or URTI) including rhinitis, sinusitis, pharyngitis, tonsillitis, laryngitis, tracheitis and otitis media. 2 Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia and acute bronchitis. 3 Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema 4 Bronchial Asthma 5 H/o Pulmonary Tuberculosis 6 Tumours of larynx, bronchi, and lungs 7 Drug-induced Cough (e.g., ACE Inhibitors) 8 Diabetes Mellitus, Hypertension 9 Known cases of severe hepatic, renal or cardiac ailments 10 H/o addiction (smoking, alcohol, drugs) 11 K/h/o hypersensitivity to herbal extracts or dietary supplements 12 Pregnant women, lactating women and women of child-bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test.

Design outcomes

Primary

MeasureTime frame
Symptomatic relief from clinical symptoms of Flu and Flu like symptomsTimepoint: 7 Days—

Secondary

MeasureTime frame
To assess the safety profile of Anacosinum pellets in Flu and overall compliance to the drug treatment.Timepoint: 7 Days—

Countries

India

Contacts

Public ContactTrupti Desai

Milagro Clinical Research

trupti@milagroclinicalresearch.com917400407193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026